Showing results (1-10 of 816) with videos related to
Sort By:
Pageof 82
The American Journal of Hospice & Palliative Care|November 30, 2000
A new concept in cancer care: the supportive care programP Esper, J N Hampton, J Finn, et al.Oncology Nursing Forum|January 28, 1999
Quality-of-life evaluation in patients receiving treatment for advanced prostate cancerP Esper, J N Hampton, D C Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancerD C Smith, P Esper, M Strawderman, et al.Seminars in Oncology|November 5, 1997
Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancerK J Pienta, D C SmithThe Urologic Clinics of North America|May 1, 1997
The use of prostate-specific antigen as a surrogate end point in the treatment of patients with hormone refractory prostate cancerD C Smith, K J PientaSeminars in Oncology|April 6, 1999
Paclitaxel in the treatment of hormone-refractory prostate cancerD C Smith, K J PientaDrugs|March 11, 2000
Oral chemotherapy in the treatment of hormone-refractory prostate cancerK J Pienta, J M Kamradt, D C SmithCancer|June 8, 2001
Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: a phase II trial of oral estramustine and oral etoposideH G Munshi, K J Pienta, D C SmithThe Urologic Clinics of North America|June 11, 1999
Oral chemotherapy for hormone refractory prostate cancer. The University of Michigan experienceJ M Kamradt, D C Smith, K J PientaUrology|January 14, 1998
Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrumentP Esper, F Mo, G Chodak, et al.Pageof 82